Abilify MyCite and Mesalamine Controlled-Release Capsules
Determining the interaction of Abilify MyCite and Mesalamine Controlled-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aripiprazole
Brand name: Abilify MyCite, Abilify, Abilify Discmelt, Abilify Maintena, Aristada, Aristada Initio
Synonyms: Abilify Mycite
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abilify MyCite-Mesalamine Delayed Release Tablets
- Abilify MyCite-Mesalamine Long-Acting Capsules (Apriso)
- Abilify MyCite-Mesalamine Long-Acting Capsules (Delzicol)
- Abilify MyCite-Mesalamine Long-Acting Capsules (Pentasa)
- Abilify MyCite-Mesalamine rectal
- Abilify MyCite-Mesalamine Rectal Enema
- Mesalamine Controlled-Release Capsules-Abiraterone
- Mesalamine Controlled-Release Capsules-Abiraterone acetate
- Mesalamine Controlled-Release Capsules-Abiraterone Acetate (Yonsa)
- Mesalamine Controlled-Release Capsules-Abiraterone Acetate (Zytiga)
- Mesalamine Controlled-Release Capsules-Ablavar
- Mesalamine Controlled-Release Capsules-Ablysinol